ATMAN
ATMAN provides automated, domain-specific medical translation and evidence-management tools to help pharmaceutical and clinical organizations convert and organize medical content. The company uses a neural-network machine-translation engine combined with self-developed algorithms and proprietary language assets tuned for subfields such as pharmacovigilance, medical devices, clinical, manufacturing and regulatory content. ATMAN is a B2B AI software provider (medical machine translation and evidence-management) that integrates machine learning, large-scale language assets, and big-data pipelines; its team includes former Microsoft researchers and winners of the WMT2019 biomedical track. The platform is deployed with multinational and Chinese pharmaceutical companies and CROs and supports scaling clinical and regulatory translation workflows across enterprise environments.
ATMAN
ATMAN provides automated, domain-specific medical translation and evidence-management tools to help pharmaceutical and clinical organizations convert and organize medical content. The company uses a neural-network machine-translation engine combined with self-developed algorithms and proprietary language assets tuned for subfields such as pharmacovigilance, medical devices, clinical, manufacturing and regulatory content. ATMAN is a B2B AI software provider (medical machine translation and evidence-management) that integrates machine learning, large-scale language assets, and big-data pipelines; its team includes former Microsoft researchers and winners of the WMT2019 biomedical track. The platform is deployed with multinational and Chinese pharmaceutical companies and CROs and supports scaling clinical and regulatory translation workflows across enterprise environments.